Millendo plans to go public through takeover of OvaScience by Conor Hale Thursday, August 9, 2018 Millendo Therapeutics plans to absorb the floundering, publicly traded OvaScience to support its endocrine-based orphan disease efforts.
Microbiome startup Axial gains DepoMed exec as new CMO by Ben Adams Tuesday, August 22, 2017 Axial Biotherapeutics has poached Srinivas G. Rao, M.D., Ph.D., from struggling DepoMed as its new chief medical officer.
